Advertisement
The absence of standards is an important barrier to pediatric oncologists recommending medical marijuana

Pediatric Oncologists Willing to Consider Medical Marijuana

0
Those eligible to certify report less favorable attitudes to medical marijuana overall
A deep learning algorithm can detect metastases in sections of lymph nodes from women with breast cancer; and a deep learning system has high sensitivity and specificity for identifying diabetic retinopathy

Artificial Intelligence Promising for CA, Retinopathy Diagnoses

0
Two studies evaluate use; one for breast cancer, the other for diabetic retinopathy
A new approach to gene therapy can restore immune cell types in infants with newly diagnosed X-linked severe combined immunodeficiency

ASH: New Approach to Gene Tx Restores Immune Cells in X-SCID

0
Efficient vector marking in bone marrow CD34+ cells, myeloid cells, B cells in newly diagnosed SCID
Health care spending growth slowed in 2016 following faster growth in 2014 and 2015

Deceleration in Health Care Spending Growth in 2016

0
Enrollment trends drove slowdown in Medicaid and private health insurance spending growth in 2016
For men with severe hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

0
Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels
For patients with advanced-stage Hodgkin's lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin’s Lymphoma

0
Lower combined risk of progression, death, or noncomplete response with A+AVD
Axicabtagene ciloleucel (axi-cel)

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

0
Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

CTRC-AACR San Antonio Breast Cancer Symposium, Dec. 5-9

0
The 40th Annual CTRC-AACR San Antonio Breast Cancer Symposium The annual meeting of the San Antonio Breast Cancer Symposium was held from Dec....
For heavily pre-treated patients with relapsed/refractory multiple myeloma

VDT PACE Effective in Relapsed, Refractory Multiple Myeloma

0
Minimal response or more in 68.4 percent of patients, partial response or more in 54.4 percent
Women who currently or recently used contemporary hormonal contraceptives have increased risk of breast cancer

Breast CA Risk Up With Recent Hormonal Contraceptive Use

0
Findings from nationwide study in Denmark show small absolute increase in breast cancer risk